Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …

Cancer patients have an increased risk of developing venous thromboembolism (VTE), a
condition that is associated with increased morbidity and mortality. Although risk assessment …

In the general population, individuals with an inherited thrombophilia have a higher risk of
thrombosis, but the effect of inherited thrombophilia on the risk of cancer‐associated venous …

PURPOSE Venous thromboembolism (VTE) is a leading cause of death among patients with
cancer. The Khorana score was developed for assessing the risk of VTE in outpatients with …

Background Patients with cancer have an increased risk for arterial thromboembolism (ATE).
Scant data exist about the impact of cancer-specific genomic alterations on the risk for ATE …

Venous thromboembolism (VTE) associated with cancer (CAT) is a well-described
complication of cancer and a leading cause of death in patients with cancer. The purpose of …

Background Venous thromboembolism (VTE) is a frequent complication in cancer patients
and is associated with significant morbidity, mortality, and burden on the health care system …

Background Inherited thrombophilia and cancer both independently increase the risk of
venous thromboembolism (VTE). However, whether the increased VTE risk associated with …

Venous thromboembolism (VTE) is a common and potentially life-threatening complication
in cancer. Patients with cancer are at a higher risk of VTE-related complications such as …

Venous thromboembolism (VTE) represents a major challenge in the management of
patients with cancer. The malignant phenotype is associated with derangements in the …